Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215431779> ?p ?o ?g. }
- W3215431779 endingPage "1369" @default.
- W3215431779 startingPage "1352" @default.
- W3215431779 abstract "Serine/threonine-protein kinases 3 and 4 (STK3 and STK4, respectively) are key components of the Hippo signaling pathway, which regulates cell proliferation and death and provides a potential therapeutic target for acute myeloid leukemia (AML). Herein, we report the structure-based design of a series of pyrrolopyrimidine derivatives as STK3 and STK4 inhibitors. In an initial screen, the compounds exhibited low nanomolar potency against both STK3 and STK4. Crystallization of compound 6 with STK4 revealed two-point hinge binding in the ATP-binding pocket. Further characterization and analysis demonstrated that compound 20 (SBP-3264) specifically inhibited the Hippo signaling pathway in cultured mammalian cells and possessed favorable pharmacokinetic and pharmacodynamic properties in mice. We show that genetic knockdown and pharmacological inhibition of STK3 and STK4 suppress the proliferation of AML cells in vitro. Thus, SBP-3264 is a valuable chemical probe for understanding the roles of STK3 and STK4 in AML and is a promising candidate for further advancement as a potential therapy." @default.
- W3215431779 created "2021-12-06" @default.
- W3215431779 creator A5000398535 @default.
- W3215431779 creator A5004382370 @default.
- W3215431779 creator A5004495022 @default.
- W3215431779 creator A5009718042 @default.
- W3215431779 creator A5012278873 @default.
- W3215431779 creator A5013336817 @default.
- W3215431779 creator A5022120474 @default.
- W3215431779 creator A5037810899 @default.
- W3215431779 creator A5039016268 @default.
- W3215431779 creator A5042569998 @default.
- W3215431779 creator A5043780670 @default.
- W3215431779 creator A5044083374 @default.
- W3215431779 creator A5044257848 @default.
- W3215431779 creator A5066757406 @default.
- W3215431779 creator A5075097409 @default.
- W3215431779 creator A5084387129 @default.
- W3215431779 date "2021-11-22" @default.
- W3215431779 modified "2023-10-11" @default.
- W3215431779 title "Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia" @default.
- W3215431779 cites W1489171502 @default.
- W3215431779 cites W1540384848 @default.
- W3215431779 cites W1664030242 @default.
- W3215431779 cites W1827782944 @default.
- W3215431779 cites W1963927300 @default.
- W3215431779 cites W1975284118 @default.
- W3215431779 cites W1986961354 @default.
- W3215431779 cites W1991110933 @default.
- W3215431779 cites W1999012914 @default.
- W3215431779 cites W2002935073 @default.
- W3215431779 cites W2003046264 @default.
- W3215431779 cites W2014949551 @default.
- W3215431779 cites W2016672123 @default.
- W3215431779 cites W2026521278 @default.
- W3215431779 cites W2055050336 @default.
- W3215431779 cites W2074473216 @default.
- W3215431779 cites W2079029484 @default.
- W3215431779 cites W2085197940 @default.
- W3215431779 cites W2092301538 @default.
- W3215431779 cites W2096335011 @default.
- W3215431779 cites W2105193974 @default.
- W3215431779 cites W2109904224 @default.
- W3215431779 cites W2117022661 @default.
- W3215431779 cites W2134956953 @default.
- W3215431779 cites W2146337514 @default.
- W3215431779 cites W2152265294 @default.
- W3215431779 cites W2162730852 @default.
- W3215431779 cites W2167978765 @default.
- W3215431779 cites W2172242534 @default.
- W3215431779 cites W2254560754 @default.
- W3215431779 cites W2296208951 @default.
- W3215431779 cites W2409945629 @default.
- W3215431779 cites W2512544075 @default.
- W3215431779 cites W2584413057 @default.
- W3215431779 cites W2605336808 @default.
- W3215431779 cites W2621388873 @default.
- W3215431779 cites W2763029597 @default.
- W3215431779 cites W2769161116 @default.
- W3215431779 cites W2803172887 @default.
- W3215431779 cites W2898284215 @default.
- W3215431779 cites W2911188335 @default.
- W3215431779 cites W2911745815 @default.
- W3215431779 cites W4210488808 @default.
- W3215431779 cites W4210675630 @default.
- W3215431779 cites W4248872320 @default.
- W3215431779 doi "https://doi.org/10.1021/acs.jmedchem.1c00804" @default.
- W3215431779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34807584" @default.
- W3215431779 hasPublicationYear "2021" @default.
- W3215431779 type Work @default.
- W3215431779 sameAs 3215431779 @default.
- W3215431779 citedByCount "10" @default.
- W3215431779 countsByYear W32154317792022 @default.
- W3215431779 countsByYear W32154317792023 @default.
- W3215431779 crossrefType "journal-article" @default.
- W3215431779 hasAuthorship W3215431779A5000398535 @default.
- W3215431779 hasAuthorship W3215431779A5004382370 @default.
- W3215431779 hasAuthorship W3215431779A5004495022 @default.
- W3215431779 hasAuthorship W3215431779A5009718042 @default.
- W3215431779 hasAuthorship W3215431779A5012278873 @default.
- W3215431779 hasAuthorship W3215431779A5013336817 @default.
- W3215431779 hasAuthorship W3215431779A5022120474 @default.
- W3215431779 hasAuthorship W3215431779A5037810899 @default.
- W3215431779 hasAuthorship W3215431779A5039016268 @default.
- W3215431779 hasAuthorship W3215431779A5042569998 @default.
- W3215431779 hasAuthorship W3215431779A5043780670 @default.
- W3215431779 hasAuthorship W3215431779A5044083374 @default.
- W3215431779 hasAuthorship W3215431779A5044257848 @default.
- W3215431779 hasAuthorship W3215431779A5066757406 @default.
- W3215431779 hasAuthorship W3215431779A5075097409 @default.
- W3215431779 hasAuthorship W3215431779A5084387129 @default.
- W3215431779 hasBestOaLocation W32154317792 @default.
- W3215431779 hasConcept C11960822 @default.
- W3215431779 hasConcept C172512520 @default.
- W3215431779 hasConcept C184235292 @default.
- W3215431779 hasConcept C185592680 @default.
- W3215431779 hasConcept C2775880066 @default.
- W3215431779 hasConcept C2776414213 @default.